(Q38043780)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22981762%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

title

The importance of pertussis in older adults: a growing case for reviewing vaccination strategy in the elderly (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22981762%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22981762%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

4

C Raina MacIntyre

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22981762%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

author name string

Iman Ridda

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22981762%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Jiehui Kevin Yin

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22981762%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Catherine King

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22981762%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

language of work or name

English

0 references

publication date

12 September 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22981762%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22981762%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

volume

30

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22981762%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

issue

48

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22981762%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

page(s)

6745-6752

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22981762%20AND%20SRC:MED&resulttype=core&format=json

Rationale for pertussis booster vaccination throughout life in Europe.

13 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.079

Efficacy of an acellular pertussis vaccine among adolescents and adults.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.079

Immunogenicity of the reduced-antigen-content dTpa vaccine (Boostrix(®)) in adults 55 years of age and over: a sub-analysis of four trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.079

Pertussis infection in adults with persistent cough

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.079

Prevalence and incidence of adult pertussis in an urban population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.079

Tetanus and Pertussis vaccines: their usefulness in the aging population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.079

A pertussis outbreak in a Wisconsin nursing home.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.079

A pertussis outbreak associated with social isolation among elderly nuns in a convent.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.079

A search for Bordetella pertussis infection in university students

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.079

Population-based incidence of pertussis among adolescents and adults, Minnesota, 1995-1996.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.079

Morbidity of pertussis in adolescents and adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.079

How best to estimate the global burden of pertussis?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.079

Severe and unrecognised: pertussis in UK infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.079

The seroepidemiology of Bordetella pertussis in Israel--Estimate of incidence of infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.079

[Pertussis: incidence, symptoms and costs]

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.079

An epidemic of pertussis among elderly people in a religious institution in The Netherlands

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.079

Hospitalization for pertussis: profiles and case costs by age.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.079

Pertussis infection among adults during the 1993 outbreak in Chicago

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.079

Pertussis before and after the introduction of acellular pertussis vaccines in Finland

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.079

The role of Bordetella infections in patients with acute exacerbation of chronic bronchitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.079

High incidence of pertussis among Hajj pilgrims.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.079

Hospital admissions for pertussis in Spain, 1995-1998.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.079

Modelling hospital admissions for lower respiratory tract infections in the elderly in England

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.079

The changing epidemiology of pertussis in the Hunter New England area and potential implications for the immunisation schedule

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.079

Evidence of pertussis clusters in three aged-care facilities in the former Macquarie Area Health Service, NSW.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.079

ANTIBODY RESPONSE TO BOOSTER DOSE OF DIPHTHERIA AND TETANUS TOXOIDS AND PERTUSSIS VACCINE.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.079

Immunizations in the elderly: do they live up to their promise?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.079

Pertussis resurgence in Canada largely caused by a cohort effect.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.079

Duration of immunity against pertussis after natural infection or vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.079

The seroepidemiology of pertussis in Australia during an epidemic period.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.079

Epidemiological features of pertussis in the United States, 1980-1989.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.079

Adult tetanus, diphtheria and pertussis immunization: knowledge, beliefs, behavior and anticipated uptake

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.079

Humoral immunity 5 years after booster immunization with an adolescent and adult formulation combined tetanus, diphtheria, and 5-component acellular pertussis vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.079

Immunity to pertussis 5 years after booster immunization during adolescence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.079

Pertussis antitoxin decay after vaccination with DTPa. Response to a first booster dose 3 1/2-6 1/2 years after the third vaccine dose

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.079

Immune responses in adults to revaccination with a tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine 10 years after a previous dose

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.079

A decennial booster dose of reduced antigen content diphtheria, tetanus, acellular pertussis vaccine (Boostrix™) is immunogenic and well tolerated in adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.079

Adolescent and adult pertussis vaccination: computer simulations of five new strategies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.079

Booster vaccination of adults with reduced-antigen-content diphtheria, Tetanus and pertussis vaccine: immunogenicity 5 years post-vaccination.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.079

Safety of Tdap-IPV given one month after Td-IPV booster in healthy young adults: a placebo-controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.079

Adult vaccination strategies for the control of pertussis in the United States: an economic evaluation including the dynamic population effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.079

Cost-effectiveness analysis of various pertussis vaccination strategies primarily aimed at protecting infants in the Netherlands

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.079

Adult immunizations: how are we doing?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.079

Pearl Kendrick, Grace Eldering, and the pertussis vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.079

What is the best way to use conjugate vaccines?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.079

Vaccination in the elderly: an immunological perspective

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.079

The incidence of Bordetella pertussis infections estimated in the population from a combination of serological surveys.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.079

Panel backs wider pertussis vaccination to curb outbreaks, prevent deaths

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.079

Inactivated split-virion seasonal influenza vaccine (Fluarix): a review of its use in the prevention of seasonal influenza in adults and the elderly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.079

Indications for acellular pertussis vaccines in adults: the case for selective, rather than universal, recommendations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.079

Infant pertussis: who was the source?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.079

Updated vaccine guidelines for aging and aged citizens of Europe

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.079

Coalition of advocates to vaccinate of Western European citizens aged 60 years and older

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.079

Advocating vaccination of adults aged 60 years and older in Western Europe: statement by the Joint Vaccine Working Group of the European Union Geriatric Medicine Society and the International Association of Gerontology and Geriatrics-European Region

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.079

[Vaccinations in adults--who? when? why?]

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.079

Immunization for the elderly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.079

Increased population prevalence of low pertussis toxin antibody levels in young children preceding a record pertussis epidemic in Australia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.079

Survey of pertussis morbidity in adults in western Sydney.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.079

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2012.08.079

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22981762%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

1 reference